Second-Line Chimeric Antigen Receptor T Cell Therapy (CAR-T) As Standard of Care for Relapsed-Refractory Large B-Cell Lymphoma (LBCL)
Saurabh Dahiya,Jay Y. Spiegel,Dasom Lee, Turab Mohammed,Forat Lutfi, Anmol Goyal, Caroline Hana,Julio C. Chavez, Filip Ionescu,Matthew J. Frank,Sushma Bharadwaj,Jose Sandoval-Sus,Amer M. Beitinjaneh,Lazaros J. Lekakis,Joseph P. McGuirk,Frederick L. Locke,David B. Miklos,Michael D. Jain BLOOD(2023)
AI 理解论文
溯源树
样例